Farhad Hafezi, MD, PhD

Professor Farhad Hafezi is a cataract & refractive surgeon and ocular cell biologist. Combining patient care, research & development, and teaching, Hafezi is considered a pioneer and key opinion leader of corneal cross-linking (CXL). Hafezi is one of the most cited ophthalmologists of his generation. His scientific contributions include over 260 articles, letters, reviews and book chapters. He has an h index of 60, more than 14.800 citations in the scientific literature, and a cumulative impact factor of 1.039 points.   • Hafezi is a member of the European Society for Cataract and Refractive Surgery (ESCRS) council since 2023. • He was voted 5 times onto the biennial PowerList100 since its start in 2014. The PowerList100 comprises the 100 most influential people in global ophthalmology.  • Since 2018, he is a FARVO, a fellow of ARVO (Association of Research in Vision and Ophthalmology). • Hafezi is an Associate Editor of the JRS (Journal of Refractive Surgery) and a council member of ESCRS (European Society for Cataract and Refractive Surgery). • Prof. Hafezi has commercialized CXL technology with the focus on democratizing access to treatment. This technology requires minimal infrastructure and increases the ease-of-use by providing pre-set integrated protocols and using one customized riboflavin for all treatments. (https://www.emagine-eye.com) • Prof. Hafezi is also the co-founder of an international charity, the Light for Sight Foundation, that is dedicated to stopping preventable blindness among children and adolescents with keratoconus. This foundation expands to 42 countries and supports education, outreach, access to treatment and research activities (https://lightforsight.org/)   For a complete bio, see: https://en.wikipedia.org/wiki/Farhad_Hafezi For more information, visit: https://www.elza-institute.com/